Improving Outcomes for NTM Patients.
Through collaboration, multi-site studies, and scientific exchange, the NTMRC advances knowledge and treatment of NTM disease.
About the Consortium
The Non-Tuberculosis Mycobacteria Research Consortium (NTMRC) was established to create a collaborative network of experts committed to advancing research on NTM disease.
By connecting institutions, clinicians, and investigators across multiple sites, the consortium enables coordinated studies, knowledge sharing, and the development of new therapeutic strategies.
Our work supports clinical research, fosters collaboration with industry and regulatory partners, and helps accelerate scientific progress in a field where improved treatments and patient outcomes are urgently needed.
The consortium supports a wide range of research initiatives focused on understanding and improving care for individuals affected by NTM disease.
- Multi-site clinical research studies
- Collaborative research networks across leading institutions
- Industry and regulatory partnerships
PATIENT STORIES
MELISA UTABE
Cardiologist, NYC
Monica
Heart Specialist, LOS
HOW WE ADVANCE NTM RESEARCH
MULTI-SITE COLLABORATION
Leading research institutions work together to share expertise, align priorities, and build a stronger network dedicated to advancing NTM research.
STUDY DEVELOPMENT
Investigators identify critical research questions and design high-quality clinical studies that address unmet needs in NTM care.
CLINICAL RESEARCH
Participating sites conduct collaborative clinical studies while collecting reliable data that helps improve understanding of NTM disease.
SCIENTIFIC IMPACT
Leading research institutions work together to share expertise, align priorities, and build a stronger network dedicated to advancing NTM research.
We are there to support you with highly efficient, evidence-based and state-of-the-art diagnostic technology. Tristique nulla aliquet enim tortor at. Massa vitae tortor condimentum lacinia. Tempus urna et pharetra pharetra massa.
